Dr. Singh highlights his presentation at the American Academy of Dermatology titled, “Beyond the Surgery: Advances in Cutaneous SCC Risk Stratification.” In addition, he explains the impact of the DecisionDx-SCC tool to enhance risk stratification for patients with cutaneous squamous cell carcinoma (SCC). He also discusses future directions and emerging treatment options for cutaneous SCC.
Topics Covered:
- Recent literature showcasing enhanced risk stratification in cutaneous squamous cell carcinoma
- Treatment decision-making in cutaneous squamous cell carcinoma
- Impact of DecisionDx-SCC test on patient outcomes